PRISM - Trademark Details
Status: 688 - Notice Of Allowance - Issued
Serial Number
88276936
Word Mark
PRISM
Status
688 - Notice Of Allowance - Issued
Status Date
2021-11-09
Filing Date
2019-01-25
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-09-14
Attorney Name
Law Office Assigned Location Code
N40
Employee Name
MMEJE, OBIEZE GINIKANW
Statements
Goods and Services
Oligonucleotide compounds for scientific or research purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery agents for scientific or research purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide compounds for scientific or research purposes for use in targeted gene silencing; drug delivery agents for scientific or research purposes consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Goods and Services
Oligonucleotide compounds for medical purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide compounds for medical purposes for use in targeted gene silencing; drug delivery agents for medical purposes consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Goods and Services
Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders
Goods and Services
Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2019-02-19
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-02-19
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (public company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (public company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (public company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Steven A. Abreu
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2019-01-29 | NEW APPLICATION ENTERED IN TRAM |
| 2019-02-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-04-08 | ASSIGNED TO EXAMINER |
| 2019-04-13 | NON-FINAL ACTION WRITTEN |
| 2019-04-13 | NON-FINAL ACTION E-MAILED |
| 2019-04-13 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-10-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-10-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-10-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-11-16 | SUSPENSION LETTER WRITTEN |
| 2019-11-16 | LETTER OF SUSPENSION E-MAILED |
| 2019-11-16 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2020-06-04 | ASSIGNED TO LIE |
| 2020-06-07 | SUSPENSION LETTER WRITTEN |
| 2020-06-07 | LETTER OF SUSPENSION E-MAILED |
| 2020-06-07 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2021-01-11 | NON-FINAL ACTION WRITTEN |
| 2021-01-11 | NON-FINAL ACTION E-MAILED |
| 2021-01-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-03-08 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-03-08 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-03-08 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-03-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-03-08 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2021-07-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-07-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-07-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-08-09 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-08-26 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-08-26 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-08-26 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-09-14 | PUBLISHED FOR OPPOSITION |
| 2021-09-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-09-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-09-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-11-09 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
